The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / REF-Funded Research Provides Prognostic Information about Childhood-onset SLE

REF-Funded Research Provides Prognostic Information about Childhood-onset SLE

April 1, 2010 • By Staff

  • Tweet
  • Email
Print-Friendly Version / Save PDF

A study recently published in Arthritis Care & Research concluded that there are differences in the outcomes of patients with childhood-onset systemic lupus erythematosus (SLE) and adult-onset SLE, which provides important prognostic information about long-term SLE disease activity and treatment.1

You Might Also Like
  • How Hospitals Rank in Treating Childhood-Onset SLE
  • 2008–2009 REF Award Recipients
  • Childhood-onset Lupus Brings Distinct Challenges at Each Phase of Life
Explore This Issue
April 2009
Also By This Author
  • ACR’s Premier Learning Venue

SLE affects 10 times as many women as men and typically develops in people in their twenties and thirties. In 2005, the prevalence of SLE was estimated at between 161,000 and 322,000, with 15% to 20% of SLE patients diagnosed during childhood, age 18 years and under. Although short-term survival rates for childhood-onset SLE have improved dramatically over the last several decades, for unknown reasons, a significant percentage of childhood-onset SLE patients still die prematurely.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The researchers used data derived from the University of California’s Lupus Outcomes Study—an observational study of 885 adult subjects with SLE, 90 of whom had childhood-onset SLE. They gathered baseline and one-year follow-up data through telephone interviews conducted between 2002 and 2006. Using self-report data on differences in organ involvement and disease morbidity, current disease status and activity, past and current medication use, and number of physician visits, they then compared the data based on age at diagnosis with SLE.

Among the researchers on the project was Aimee O. Hersh, MD, a recent recipient of the ACR Research and Education Foundation (REF) Physician Scientist Development Award. When Dr. Hersh and her colleagues set out to compare the differences in long-term outcomes between adults with childhood-onset SLE and adults with adult-onset SLE, the hope was that their findings would eventually help clinicians design interventions to improve outcomes for patients with childhood-onset SLE.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“We found that patients with childhood-onset SLE were more likely to have renal disease, which was expected. But we also found that there were similar outcomes with other co-morbidities, like clotting disorders, seizures, and myocardial infarction,” explains Dr. Hersh.

The researchers also found that at follow-up, patients with childhood-onset SLE were more likely to be taking steroids and other immunosuppressive therapies and reported a higher number of nephrology visits than the patients with adult-onset SLE. “This study provides prognostic information on co-morbidities that had not been studied before,” says Dr. Hersh. “As a pediatric rheumatologist taking care of these patients, I’m asked ‘Will I have to take these medications forever?’ so studies like these are important so that we can educate our patients about future outcomes and so we can discuss the practical interventions to prevent these other co-morbidities.”

Pages: 1 2 | Single Page

Filed Under: From the College Tagged With: REF News, Research, Systemic lupus erythematosusIssue: April 2009

You Might Also Like:
  • How Hospitals Rank in Treating Childhood-Onset SLE
  • 2008–2009 REF Award Recipients
  • Childhood-onset Lupus Brings Distinct Challenges at Each Phase of Life
  • Within Our Reach–Funded Research Finds Highly Specific Markers of RA

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)